1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Cirrhosis Global Clinical Trials Review, H1, 2015

Cirrhosis Global Clinical Trials Review, H1, 2015

  • January 2015
  • -
  • GlobalData
  • -
  • 118 pages

Cirrhosis Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Cirrhosis Global Clinical Trials Review, H1, 2015" provides data on the Cirrhosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cirrhosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cirrhosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Cirrhosis Global Clinical Trials Review, H1, 2015
Introduction 6
Cirrhosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cirrhosis to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cirrhosis to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cirrhosis 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Cirrhosis Therapeutics Clinical Trials 32
Prominent Drugs 33
Latest Clinical Trials News on Cirrhosis 34
Nov 08, 2014: Phase 3 UNITY Trials Demonstrate High Cure Rates for Investigational, All-Oral Daclatasvir TRIO Fixed-Dose Combination in Genotype 1 Hepatitis C Patients, Including Those with Cirrhosis 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Merck and Co., Inc. 35
Clinical Trial Overview of Merck and Co., Inc. 35
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Genextra S.p.a. 37
Clinical Trial Overview of Genextra S.p.a. 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
F. Hoffmann-La Roche Ltd. 39
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 39
Zambon Company S.p.A. 40
Clinical Trial Overview of Zambon Company S.p.A. 40
Sanofi 41
Clinical Trial Overview of Sanofi 41
Otsuka Holdings Co., Ltd. 42
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 42
AbbVie Inc. 43
Clinical Trial Overview of AbbVie Inc. 43
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
Clinical Trial Overview of Top Institutes / Government 45
Hospital Clinic de Barcelona 45
Clinical Trial Overview of Hospital Clinic de Barcelona 45
The National Institute of Diabetes and Digestive and Kidney Diseases 46
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 46
Assistance Publique - Hopitaux de Paris 47
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 47
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 48
Clinical Trial Overview of Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 48
Govind Ballabh Pant Hospital 49
Clinical Trial Overview of Govind Ballabh Pant Hospital 49
Institute of Liver and Biliary Sciences 50
Clinical Trial Overview of Institute of Liver and Biliary Sciences 50
Sun Yat-sen University 51
Clinical Trial Overview of Sun Yat-sen University 51
Beijing Friendship Hospital 52
Clinical Trial Overview of Beijing Friendship Hospital 52
Mayo Clinic 53
Clinical Trial Overview of Mayo Clinic 53
Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 54
Clinical Trial Overview of Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 54
Five Key Clinical Profiles 55
Appendix 115
Abbreviations 115
Definitions 115
Research Methodology 116
Secondary Research 116
About GlobalData 117
Contact Us 117
Disclaimer 117
Source 118

List of Tables

Cirrhosis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Cirrhosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Cirrhosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Cirrhosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Cirrhosis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Cirrhosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Cirrhosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Cirrhosis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Cirrhosis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Cirrhosis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Cirrhosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Cirrhosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Cirrhosis Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Cirrhosis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Cirrhosis Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Cirrhosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Cirrhosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30
Cirrhosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Cirrhosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Cirrhosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 35
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 36
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Genextra S.p.a., 2015* 37
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 38
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 39
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zambon Company S.p.A., 2015* 40
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 41
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 42
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 43
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 44
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2015* 45
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 46
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 47
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, 2015* 48
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Govind Ballabh Pant Hospital, 2015* 49
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Liver and Biliary Sciences, 2015* 50
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 51
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Friendship Hospital, 2015* 52
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 53
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, 2015* 54

List of Figures

Cirrhosis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Cirrhosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Cirrhosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Cirrhosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Cirrhosis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Cirrhosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Cirrhosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Cirrhosis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Cirrhosis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Cirrhosis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Cirrhosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Cirrhosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Cirrhosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Cirrhosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30
Cirrhosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Cirrhosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Cirrhosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
GlobalData Methodology 116

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Non-alcoholic Steatohepatitis Biomarkers Market and Pharmaceutical Industry, Academic Research Institute, Hospitals, and Diagnostic Laboratories - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Non-alcoholic Steatohepatitis Biomarkers Market and Pharmaceutical Industry, Academic Research Institute, Hospitals, and Diagnostic Laboratories - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Non-alcoholic Steatohepatitis Biomarker Market: Overview Non-alcoholic steatohepatitis (NASH) is liver disease which is categorized under the spectrum of non-alcoholic fatty liver disease (NAFLD). ...

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global human microbiome market is estimated to reach USD 899.1 million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025) Factors such as increased focus on human microbiome ...

Epiomic Epidemiology Series: Irritable Bowel Syndrome Forecast in 12 Major Markets 2017-2027

Epiomic Epidemiology Series: Irritable Bowel Syndrome Forecast in 12 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • February 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Irritable Bowel Syndrome in 12 Major Markets Irritable Bowel Syndrome (IBS) is a functional bowel disorder which incorporates a group ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.